Accel-Heal Technologies

Accel-Heal Technologies is a private, commercial-stage company offering a clinically validated, wearable medical device for chronic wound care. Its core technology leverages microcurrent electrical stimulation (EST), a modality backed by substantial evidence including meta-analyses and RCTs, to reactivate stalled healing processes and reduce pain. The company's strategy centers on making this traditionally complex therapy simple and cost-effective for use across care settings, including patient self-management at home. Recent milestones include securing tenders (e.g., Emirates Health Services) and expanding distribution into new regions like the Nordics.

Microcurrent Electrical Stimulation (MES/EST) therapy delivered via a wearable device to restore the body's natural 'current of injury' bioelectric signal to stimulate healing in chronic wounds.

Accel-Heal competes in the advanced wound care market dominated by large players like Smith & Nephew, Mölnlycke, and ConvaTec that offer advanced dressings, biologics, and negative pressure wound therapy. Its differentiation lies in providing a simple, wearable form of electrical stimulation therapy, a modality with strong evidence but historically limited by complexity of delivery.